AI assistant
Sending…
IGC Pharma, Inc. — Director's Dealing 2021
Mar 8, 2021
34705_dirs_2021-03-08_fb6158fd-7bf3-467a-9c51-99125350e456.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2021-03-03
Reporting Person: PRINS RICHARD K (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-10 | Common Stock | G | 25000 | $0.00 | Disposed | 720000 | Direct |
| 2021-03-03 | Common Stock | S | 500 | $1.81 | Disposed | 719500 | Direct |
| 2021-03-03 | Common Stock | S | 49500 | $1.80 | Disposed | 670000 | Direct |
More from IGC Pharma, Inc.
Capital/Financing Update
2026
Jun 8
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 18
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Jan 20
Capital/Financing Update
2026
Jan 6
Regulatory Filings
2026
Jan 2
Capital/Financing Update
2025
Dec 15